Milestones

2020 was a monumental year for Curative. We’re reflecting on stories from our early days, and spotlighting some of our most prominent successes, including testimonials from our partners.

Stories from Our Founders

Early Employees

Anna Bui | Program Manager

What was it like working at Curative in the early stages of the pandemic?

It was absolutely thrilling. Everything moved so quickly. It felt like a blur. The lockdowns and curfews made it easy to prioritize working more. There were very long days for months, but it was so exciting! People wore a lot of hats and took on different responsibilities as we tried to scale quickly and build the team. In the early days, we brought on a lot of people. There were volunteers who joined to help fight the pandemic. I have never seen so many people come together for a cause. Startups are mission-driven and the mission was to help the world. It was humbling. The long hours we put in were very much worth it!

“Startups are mission-driven and the mission was to help the world.”

How has it been witnessing Curative’s growth?

Curative’s growth is unreal. I’m always in awe. A pivotal moment I remember is having the opportunity to see the DC lab being built. I was remote after the team moved to San Dimas. It’s one thing to witness Curative’s growth through my computer. But meeting everyone in real life and seeing all the moving parts come together to become a fully-functioning high capacity lab was such a defining moment. To this day, we have continuously improved by building incredibly talented and diverse teams. I believe our diversity has ensured we have the ability to stay at the forefront of the pandemic. This adaptability and creative thinking allow us to innovate in ways Curative would not have imagined at the beginning.

What are your hopes for the future of Curative?

When Fred started Curative, it was only supposed to last for a few months. To our surprise, the pandemic continued and still remains unpredictable. The intent was to end COVID-19, but the fight is far from over. Delta, vaccine passports, boosters, and COVID-fatigue are variables we cannot contain. We realized that Curative could make a big difference for so many individuals. We learned so much throughout this adventure. One thing we always emphasize is to always prioritize the patient experience and ensure that everyone has their healthcare needs met. My hope is for us to never lose sight of that as we define the next phase of Curative.

Katie Bond | Associate Director of Nanopore Sequencing

What was it like working at Curative in the early stages of the pandemic?

In the very early stages of Curative, we recognized the needs of the pandemic and began to focus on that. It was a small team and everyone knew everyone. Fred found Korva Labs who would partner with us to do COVID testing from their labs. We went to LA for a week, and never came back — March 14 was the day we flew to LA. The first two months were my favorite months — March and April — because everyone was so excited about working on something that was meaningful. I really liked the camaraderie and challenge — we were eating breakfast, lunch, and dinner together at the labs, even on the weekend. It was great to see people excited about their work. Pivoting from sepsis to COVID-19 was the right decision in the long run — it was moving too fast for me to stop and think about it. I was happy we were doing something for the world.

“We had no infrastructure to do what we did — and we were able to hit high numbers and make an impact.”

How has it been witnessing Curative’s growth?

It’s a good thing that we’ve been able to give people jobs and grow across the country. It required all of the team to be very dynamic and adapt to fast-changing scenarios. We had no infrastructure to do what we did — and we were able to hit high numbers and make an impact.

What are your hopes for the future of Curative?

I hope that Curative will have a sustainable plan for how to continue to provide healthcare resources to those who need them. As we rebrand to become a comprehensive healthcare company, it would be great to reinvest in research and development so we can continue our search for solutions to hard problems.

Ernest Templin | Head of Rapid Molecular Diagnostics

What was it like working at Curative in the early stages of the pandemic?

Early Curative was characterized by rapid changes and new directions. We were working in our tiny four-room lab in Menlo Park when Fred and Vlad came up to us and said “Hey, we’re thinking about doing this COVID testing thing. Can you do research on different machines and testing devices?” Next thing I know I was living in a hotel in LA, working 14-16 hour days, just getting it done. In retrospect, I wouldn’t have done anything differently. We’re helping with the pandemic — it helped to do something to that end. Curative is creating a community of people with a moral vision to help people and the world. We were all there from 8 am -1 am, but it didn’t feel like we were burning out. We were hanging out with smart, intelligent people who stepped up to get the job done.

“It’s unbelievable to see the growth — I kind of get goosebumps when I see a Curative van drive by.”

How has it been witnessing Curative’s growth?

It’s unbelievable to see the growth — I kind of get goosebumps when I see a Curative van drive by. Looking at the number of the Slack channel members increasing by several hundred every day for 6 months — it’s really unreal. I can’t think of a better word to describe it — it makes me proud and makes me think that we did something that’s useful.

What are your hopes for the future of Curative?

Curative can really change the game in terms of the incentive structures. If we can really execute on putting the patient first, we can realign healthcare insurance incentives with patient incentives to make sure people are healthy and happy.

Regional Highlights

Team West

Jamil Sabbagh, General Manager

Notable Partnerships

California

I always felt the real goal for Curative was to end this pandemic. While we've still got lots of work to do (with the different variants on the rise), I believe Curative has been an integral part in getting to where we are right now (ability to see friends, family & loved ones, no longer having to wear a mask outdoors, back to some sort of "normal"). Specifically, in California, I feel the ultimate goal is to accommodate testing in every county across the state.

“Curative has been a leader in fighting this pandemic since day one. In California, we've successfully tested over 6.6 million individuals and vaccinated over 1 million individuals.”

Curative has become a very recognizable healthcare brand. Early on in the pandemic, Curative put together a team of motivated individuals to open and operate the largest COVID-19 testing drive-thru in the world at Dodger's Stadium in Los Angeles. At its peak, our staff tested over 11,000 patients per day! Soon afterward, this site transitioned to a vaccination hub and in a short period of time managed over 160,000 vaccinations.

Texas

In Texas, we have tested over 4.6 million individuals and enabled over 320,000 vaccinations. With this said, it's safe to say Curative is extremely proud of the entire team's effort in saving an incalculable amount of lives and having such a long-lasting impact on overall health outcomes across both regions, the entire country, and ultimately, the world. Similar to California, the goal for Texas would be to expand testing into as many counties as possible, making it easy and accessible for Texans to get tested.

In Texas, we've rapidly scaled from two lone testing sites in September 2020 to over 80 Curative-operated testing sites in less than half a year's time! At our peak, Curative had three Next Generation Testing (NGT) assets (mobile vans/kiosks/trailers) collecting over 1,000 tests per day, an additional four NGT assets collecting 800+ tests per day, and dozens more collecting over 500 tests per day! Curative has continuously been one of the largest COVID-19 testing partners in Texas and California and we currently operate over 200 testing sites across both states!

I always felt the real goal for Curative was to end this pandemic. While we've still got lots of work to do (with the different variants on the rise), I believe Curative has been an integral part in getting to where we are right now and will play a crucial role in our return to life as "normal."

Team Southeast

Ray Plasterer, General Manager

Notable Partnerships

Florida

Seeing Curative’s evolution in Florida has been heartwarming and inspiring. We started with a nursing home contract and have now expanded to become the state’s largest diagnostic lab, processing over 30% of the tests state-wide. To date, we’ve conducted 4.1 million tests, with an average of 220,000 tests per week, and we still see the potential to grow and better serve the Florida community. This wouldn’t be possible without the hard work of our nurses, directors, managers, and everyone who keeps each test site moving.

“As with all things COVID-19, you need to be prepared for unexpected and rapid changes. We've had to quickly adapt to new guidance from state and federal officials. This challenge seemed insurmountable, but we were determined to do everything we could to make it a reality. Curative is a company designed to meet changing needs.”

Our priority in the Florida region has always been to provide options to the populations that need it most. That journey started with nursing homes. Since the beginning, the response to our work was overwhelmingly positive. Our nursing home partners were grateful to have our rapid and reliable tests so that they can continue to ensure the health of their staff and patients.

Team National

Dean Shultis, Senior VP of Supply Chain and

National Field Operations

Notable Partnerships

The National Field Operations (NFO) team has been instrumental in meeting Curative’s mission to end the COVID-19 pandemic in the United States. Over the past year, we have been building the proper regional structure to expand Curative’s COVID-19 services footprint across the country. We have strengthened current partnerships and established operations in new states through cost-effective, streamlined, and flexible operational models and dedicated regional growth and sales efforts.

“Our continued vaccination efforts, combining low cost solutions with willingness to meet partner expectations resulted in partners reaching out to us to conduct testing in addition to vaccination distribution.”

When we started the team back in late September of 2020, NFO was operating in only nine states--Alaska, Colorado, D.C., Delaware, Illinois, Louisiana, Michigan, Pennsylvania, and Wyoming--and collecting an average of 25K test samples per week. As we grew the team, our objective was to expand in current markets, penetrate new ones, and reach a weekly collection volume of roughly 30% of Curative’s overall volume. At the peak of the COVID-19 pandemic, NFO was collecting a record of 188,000 test samples per week and operating in over 18 states with many different testing models as we adjusted to the state-by-state requirements. To date, NFO has provided ~over 4.2 million tests to patients across the country.